255 related articles for article (PubMed ID: 25986785)
1. Evaluating the safety and efficacy of recombinant human thrombopoietin among severe sepsis patients with thrombocytopenia: study protocol for a randomized controlled trial.
Wu Q; Ren J; Wang G; Gu G; Hu D; Liu S; Li G; Chen J; Li R; Hong Z; Ren H; Wu X; Li Y; Yao M; Zhao Y; Li J
Trials; 2015 May; 16():220. PubMed ID: 25986785
[TBL] [Abstract][Full Text] [Related]
2. The effect of recombinant human thrombopoietin (rhTPO) on sepsis patients with acute severe thrombocytopenia: a study protocol for a multicentre randomised controlled trial (RESCUE trial).
Zhou Z; Feng T; Xie Y; Huang P; Xie H; Tian R; Qian B; Wang R
BMC Infect Dis; 2019 Sep; 19(1):780. PubMed ID: 31492102
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human thrombopoietin improves platelet counts and reduces platelet transfusion possibility among patients with severe sepsis and thrombocytopenia: a prospective study.
Wu Q; Ren J; Wu X; Wang G; Gu G; Liu S; Wu Y; Hu D; Zhao Y; Li J
J Crit Care; 2014 Jun; 29(3):362-6. PubMed ID: 24405656
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human thrombopoietin in critically ill patients with sepsis-associated thrombocytopenia: A clinical study.
Liu Y; Jin G; Sun J; Wang X; Guo L
Int J Infect Dis; 2020 Sep; 98():144-149. PubMed ID: 32561426
[TBL] [Abstract][Full Text] [Related]
5. [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia].
Bai CM; Zou XY; Zhao YQ; Han SM; Shan YD;
Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):397-400. PubMed ID: 15061993
[TBL] [Abstract][Full Text] [Related]
6. [Consensus on clinical diagnosis, treatment and prevention management of chemotherapy induced thrombocytopenia in China(2018)].
Consensus Committee of Chemotherapy Induced Thrombocytopenia, Chinese Society of Clinical Oncology
Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):714-720. PubMed ID: 30293399
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human thrombopoietin alleviates infection-associated thrombocytopenia: a retrospective study in senile patients.
Lin J; Zhu H; Li S; Fan H; Lu X
Clin Appl Thromb Hemost; 2015 Jan; 21(1):19-24. PubMed ID: 23637005
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in lung cancer patients].
Xu YH; Chen ZW; Ye XY; Lu S
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):716-9. PubMed ID: 19173920
[TBL] [Abstract][Full Text] [Related]
10. Memorial lecture. Megakaryocytic growth factors: is there a new approach for management of thrombocytopenia in patients with malignancies?
Hofmann WK; Ottmann OG; Hoelzer D
Leukemia; 1999 Apr; 13 Suppl 1():S14-8. PubMed ID: 10232362
[TBL] [Abstract][Full Text] [Related]
11. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
Bai CM; Xu GX; Zhao YQ; Han SM; Shan YD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
[TBL] [Abstract][Full Text] [Related]
12. Technology evaluation: thrombopoietin, Genentech/Pharmacia & Upjohn.
Goldberg J
Curr Opin Mol Ther; 2000 Apr; 2(2):211-5. PubMed ID: 11249644
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human thrombopoietin: basic biology and evaluation of clinical studies.
Kuter DJ; Begley CG
Blood; 2002 Nov; 100(10):3457-69. PubMed ID: 12411315
[TBL] [Abstract][Full Text] [Related]
14. Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.
Newland A
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S35-45. PubMed ID: 18096471
[TBL] [Abstract][Full Text] [Related]
15. A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia.
Wang S; Yang R; Zou P; Hou M; Wu D; Shen Z; Lu X; Li Y; Chen X; Niu T; Sun H; Yu L; Wang Z; Zhang Y; Chang N; Zhang G; Zhao Y
Int J Hematol; 2012 Aug; 96(2):222-8. PubMed ID: 22753022
[TBL] [Abstract][Full Text] [Related]
16. [Value of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
Dai XF; Yu J; Liu L; Wu G
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):623-5. PubMed ID: 19102944
[TBL] [Abstract][Full Text] [Related]
17. New insights into thrombopoiesis in neonatal sepsis.
Eissa DS; El-Farrash RA
Platelets; 2013; 24(2):122-8. PubMed ID: 22746320
[TBL] [Abstract][Full Text] [Related]
18. A Network Meta-Analysis of Two Doses of Recombinant Human Thrombopoietin for Treating Sepsis-Related Thrombocytopenia.
Chen D; Hou Y; Wei C; Cai X
Int J Clin Pract; 2022; 2022():2124019. PubMed ID: 36683598
[TBL] [Abstract][Full Text] [Related]
19. Thrombopoietin levels in patients with disorders of platelet production: diagnostic potential and utility in predicting response to TPO receptor agonists.
Makar RS; Zhukov OS; Sahud MA; Kuter DJ
Am J Hematol; 2013 Dec; 88(12):1041-4. PubMed ID: 23913253
[TBL] [Abstract][Full Text] [Related]
20. Thrombopoiesis-stimulating agents and myelodysplastic syndromes.
Brierley CK; Steensma DP
Br J Haematol; 2015 May; 169(3):309-23. PubMed ID: 25659186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
